The commons science and technology committee are looking at the commercialisation of research. If life sciences is going to be a growth area for the UK economy, we have to be good not just at doing the research but translating what we’ve found out into commercial applications, i.e. things we can make and sell and… [Read more…]
With the details of almost every person in the UK, the health records held by the NHS are an invaluable resource for researchers. George Osborne reiterated the value of data in his autumn statement, highlighting it as a driver of growth through research and innovation and David Cameron spoke of it today. With this in… [Read more…]
The Health Research Authority - the planned new single regulator of health research across the UK – came into a being as a special health authority on Thursday. It had its first board meeting and has published a plan of action for its initial four months of operation. The Lords are also set to discuss what… [Read more…]
George Osborne made his autumn statement today. This included an extra £200 million investment in science, some new measures to support small and medium sized enterprises and an update of the plan for growth – both reporting on what the government have achieved so far and setting out some new objectives. He also confirmed that… [Read more…]
A new report published by BIS comparing the UK against other research-intensive nations highlights the international strength of the UK research community but also warns that it is under threat from underfunding and a decreasing share of the international scientific workforce. The report includes some pretty interesting statistics about research in the UK, comparing what… [Read more…]
The European Court of Justice made a decision yesterday which effectively bans the patenting of scientific techniques involving embryonic stem cells, even if the technique itself does not directly destroy an embryo but at some stage in the process has involved the use of an embryo. This has no effect on us doing research using… [Read more…]
On 6th October the government launched two new NIHR translational research partnerships that will focus on two disease areas: inflammatory respiratory disease and joint and related inflammatory disease. These are a continuation of the Therapeutic Capability Clusters trialed last year aimed at bringing together experts in the NHS and academia and outside funders to try… [Read more…]
January 15, 2012 by beckypurvis
0